Invention Grant
US09359339B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
有权
胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
- Patent Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
- Patent Title (中): 胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
-
Application No.: US14452143Application Date: 2014-08-05
-
Publication No.: US09359339B2Publication Date: 2016-06-07
- Inventor: Songnian Lin , Fengqi Zhang , Emma R. Parmee , Sunita V. Dewnani
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cocuzzo; Catherine D. Fitch
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D333/24 ; C07D409/12 ; C07D413/04 ; C07D333/60 ; C07D409/04
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US20150018399A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Public/Granted day:2015-01-15
Information query
